TARA-002 is an investigational cellular therapy
based on OK-432, an immunostimulant, currently approved in Japan and Taiwan, that has been the standard of care for LMs for over 20 years.
HemaCare is a global leader in the customization of human- derived biological products and services for biomedical research, drug discovery and cellular therapy
Acquiring this technology will allow Celling to combine their unique cellular therapy
devices with the existing ThermiGen technology to offer physicians a unique scientific approach to treat their patience.
Actinium Pharmaceuticals announced that new data from the ongoing pivotal Phase 3 SIERRA trial for Iomab-B was reported in a late breaking oral presentation at the 2019 Transplantation & Cellular Therapy
Meetings of ASBMT and CIBMTR that was held on February 20th - 24th.
The partnership will integrate Genentech's global cancer immunotherapy research and development leadership with Adaptive's proprietary T-cell receptor discovery and immune profiling platform to accelerate a transformational new treatment paradigm of tailoring cellular therapy
for each patient's individual cancer.
is a private Delaware corporation that leverages its globally integrated science, development and informatics teams to accelerate the design, high-throughput screening, discovery and development of adoptive cellular therapy
MCKINNEY, MD, Assistant Professor of Medicine, Division of Hematologic Malignancies and Cellular Therapy
"The acquisition of Kite establishes Gilead as a leader in cellular therapy
and provides a foundation from which to drive continued innovation for people with advanced cancers," said John F.
Cord blood banking is believed to provide the stem cells needed to replace and regenerate damaged bone marrow, treat blood cancers, and be a potential source for cellular therapy
and regenerative medicine.
The International Society for Cellular Therapy
(Vancouver, B.C.), established in 1992, represents 1,300 clinicians, regulators, researchers, technologists and industry partners in 50 countries.
presents readers with a collection of contributions that discuss the current status of cellular therapy
for a range of neurological disorders and injuries, including traumatic brain injury, ischemic and hemorrhagic stroke, and spinal cord injury.